Author Archive
Stories written by George

EVP, CFO and Treasurer of HomeTrust Bancshares, Inc. (U.S.: Nasdaq:HTBI), Vuncannon Tony J., sells 15,000 shares worth $471,528

According to HomeTrust Bancshares, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 10:32 AM, company EVP, CFO and Treasurer, Vuncannon Tony J. disclosed selling 15,000 shares at a cost of $31.44. At the time of this transaction (Nov 18), this trade was worth $471,528 […]

Director of Perma-Pipe International Holdings, Inc. (U.S.: Nasdaq:PPIH), Walker Jerome T., sells 1,532 shares worth $12,716

According to Perma-Pipe International Holdings, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 10:18 AM, company Director, Walker Jerome T. disclosed selling 1,532 shares at a cost of $8.30. At the time of this transaction (Nov 17), this trade was worth $12,716 in total. […]

Vice President and Controller of PUBLIC SERVICE ENTERPRISE GROUP INC (U.S.: NYSE:PEG), Chernick Rose M, sells 400 shares worth $25,060

According to PUBLIC SERVICE ENTERPRISE GROUP INC’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 10:08 AM, company Vice President and Controller, Chernick Rose M disclosed selling 400 shares at a cost of $62.65. At the time of this transaction (Nov 17), this trade was […]

Chief Executive Officer of CORE MOLDING TECHNOLOGIES INC (U.S.: NYSE American:CMT), Duvall David L., buys 1,000 shares worth $9,490

According to CORE MOLDING TECHNOLOGIES INC’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 10:15 AM, company Chief Executive Officer, Duvall David L. disclosed buying 1,000 shares at a cost of $9.49. At the time of this transaction (Nov 18), this trade was worth $9,490 […]

Interim CEO and CFO of CorMedix Inc. (U.S.: Nasdaq:CRMD), David Matthew T, buys 1,000 shares worth $5,070

According to CorMedix Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 09:53 AM, company Interim CEO and CFO, David Matthew T disclosed buying 1,000 shares at a cost of $5.07. At the time of this transaction (Nov 17), this trade was worth $5,070 in […]

Director of Forian Inc. (U.S.: Nasdaq:FORA), Wygod Martin J, buys 10,071 shares worth $98,192

According to Forian Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 09:40 AM, company Director, Wygod Martin J disclosed buying 10,071 shares at a cost of $9.75. At the time of this transaction (Nov 18), this trade was worth $98,192 in total. As of […]

Director of Forian Inc. (U.S.: Nasdaq:FORA), Wygod Martin J, buys 4,811 shares worth $47,292

According to Forian Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 09:40 AM, company Director, Wygod Martin J disclosed buying 4,811 shares at a cost of $9.83. At the time of this transaction (Nov 17), this trade was worth $47,292 in total. As of […]

Director of ABERDEEN AUSTRALIA EQUITY FUND INC (U.S.: NYSE American:IAF), Ajmera Radhika, buys 1,000 shares worth $6,146

According to ABERDEEN AUSTRALIA EQUITY FUND INC’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 09:36 AM, company Director, Ajmera Radhika disclosed buying 1,000 shares at a cost of $6.15. At the time of this transaction (Nov 18), this trade was worth $6,146 in total. […]

Director of ABERDEEN GLOBAL INCOME FUND INC (U.S.: NYSE American:FCO), Ajmera Radhika, buys 1,000 shares worth $8,285

According to ABERDEEN GLOBAL INCOME FUND INC’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 09:31 AM, company Director, Ajmera Radhika disclosed buying 1,000 shares at a cost of $8.28. At the time of this transaction (Nov 18), this trade was worth $8,285 in total. […]

CEO and Director of Indaptus Therapeutics, Inc. (U.S.: Nasdaq:INDP), Meckler Jeffrey A, buys 11,187 shares worth $65,108

According to Indaptus Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 09:16 AM, company CEO and Director, Meckler Jeffrey A disclosed buying 11,187 shares at a cost of $5.82. At the time of this transaction (Nov 18), this trade was worth $65,108 in […]

Featured Press Releases

Photo Gallery

Log in